European registry launches to monitor robotic surgery safety

NCT ID NCT03385109

Terminated Knowledge-focused Sponsor: Asensus Surgical Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This observational registry is following 500 patients aged 18–80 who undergo robotic-assisted laparoscopic surgery using the Senhance Surgical System. The goal is to track any adverse events and gather real-world safety data across urology, abdominal, thoracic, and gynecologic procedures. No new treatment is being tested; instead, the registry collects information to better understand the risks and outcomes of this robotic surgical device.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Senhance Surgical System (robotic surgical device)
What this could lead to: If successful, this registry will provide real-world safety data on robotic-assisted laparoscopic surgeries, potentially guiding future surgical practices.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient selection or surgical techniques across centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SURGERY

Contacts and locations

Locations

St. Marien-Krankenhaus

Siegen, 57072, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.